Endo to Announce First-Quarter 2022 Financial Results
The dial-in number to access the call is
A replay of the call will be available from
A simultaneous webcast of the call can be accessed by visiting http://investor.endo.com/events-and-presentations. In addition, a replay of the webcast will be available on the Company website for one year following the event.
Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-announce-first-quarter-2022-financial-results-301524199.html
Media: Heather Zoumas-Lubeski, (484) 216-6829, firstname.lastname@example.org, Investors: Pravesh Khandelwal, (845) 364-4833, email@example.com